Physician profile
Haley Daigle
NPI 1942658596
$11,635.44
in general payments reported to CMS, 2019-2025
29 companies · $2,135 in 2025
The $2,135 reported for 2025 was more than what 82% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,127 · 2020: $367 · 2021: $1,115 · 2022: $3,030 · 2023: $2,135 · 2024: $1,726 · 2025: $2,135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,764 · Travel and Lodging: $2,233 · Education: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,764.00 |
| Travel and Lodging | $2,232.62 |
| Education | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,920.14 | 2019-2024 | Davinci Xi, Da Vinci Surgical System, Da Vinci Sp |
| Davol INC. | $2,025.98 | 2024-2025 | Phasix Mesh, Arista, Surgiphor |
| Becton, Dickinson and Company | $1,124.61 | 2024 | Phasix Mesh |
| Medtronic, INC. | $1,038.34 | 2022-2025 | Sonicision, Progrip, Transorb |
| Novo Nordisk INC | $205.00 | 2020-2022 | |
| Eagle Pharmaceuticals, INC. | $150.42 | 2023 | |
| W. L. Gore & Associates, INC. | $146.64 | 2022 | |
| Daiichi Sankyo INC. | $132.67 | 2021-2023 | Injectafer |
| Medtronic Vascular, INC. | $128.33 | 2020 | |
| Evoke Pharma, INC. | $120.32 | 2023 | Gimoti |
| Conmed Corporation | $96.35 | 2023 | Airseal |
| Baxter Healthcare | $75.96 | 2022-2025 | Tisseel |
| Takeda Pharmaceuticals U.S.A., INC. | $59.13 | 2022-2023 | Gattex |
| Teleflex LLC | $54.36 | 2025 | Titan Sgs Bailout Chuck |
| Pacira Pharmaceuticals Incorporated | $40.89 | 2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanara Medtech INC. | $36.67 | 2022-2023 | Celleraterx |
| Kowa Pharmaceuticals America, INC. | $34.15 | 2022 | |
| Heron Therapeutics, INC. | $34.06 | 2021 | |
| Abbvie INC. | $31.22 | 2021-2022 | |
| Currax Pharmaceuticals LLC | $24.39 | 2022-2023 | Contrave |
| Lucid Diagnostics INC. | $22.90 | 2023 | |
| Hologic Sales and Service, LLC | $22.47 | 2023 | Coolseal Generator |
| Lilly USA, LLC | $18.22 | 2023 | Zepbound |
| Tela Bio, INC. | $17.68 | 2024 | Ovitex 2s |
| Intra-Sana Laboratories | $16.03 | 2023 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Ipsen Biopharmaceuticals, INC | $15.83 | 2022 | |
| Endo Pharmaceuticals INC. | $14.92 | 2022 | |
| Shire North American Group INC | $14.74 | 2019 | |
| Janssen Pharmaceuticals, INC | $13.02 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haley Daigle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.